Perflow Medical Expands Product Line With First Clinical Use of Stream ™ 17 Dynamic Neurothrombectomy Net

Friday, April 30, 2021

Perflow Medical, an Israel-based private innovator for neurovascular therapy, announced the successful first clinical use of the Stream ™ 17 dynamic neurothrombectomy net, a low profile designed for tortuous anatomical structures, to effectively treat patients with hemorrhagic and ischemic strokes. Built on patented CEREBRAL NET ™ technology, the Stream17 device is the latest addition to the product portfolio which also includes the recently released Cascade ™ 17 non-occlusive dynamic reshaping net for helical embolization of intracranial aneurysms. These low profile products further increase the number of blood vessels that can now be treated with Perflow's unique technology, CEREBRAL NET. The first clinical procedures were successfully performed by Professor Karlis Kupcs, head of the radiology department at the Pauls Stradins Clinical University Hospital inRiga , Latvia.

“We recently introduced the Stream family of products to our facility and I have been very pleased with the additional control the physician has and the positive results achieved using this new generation of transient stent in my career,” said commented Professor Karlis Kupcs. “With the Stream17, I appreciate being able to navigate through a small 430 μm microcatheter to effectively remove thrombus in vessels in a more distal position. In addition, the device was easy to use and allowed efficient and complete recanalization of the vessel. "

Additionally, Dr Paul Bhogal, Interventional Radiologist at Barts Health NHS Trust in London, UK, highlights the value of Perflow's product portfolio in innovation in modern neurovascular medicine. “Our center is one of the most active in the country when it comes to stroke, with a full range of treatments and consistently excellent clinical results. As part of this achievement, we believe in the value of adopting promising new tools, such as Perflow's dynamic control mesh devices, and have incorporated them into our toolkit. I'm particularly excited about the Stream17, which provides access to previously inaccessible obstructions. "

With the addition of Stream17, Perflow now offers a full line of stroke products to perform mechanical thrombectomy from proximal large vessel occlusions to distal blood clots in distal M2 / M3 segments. The Cascade Net and Stream Net product families are both available in the European market for the treatment of intracranial aneurysms and acute ischemic stroke, respectively. Perflow products are not yet licensed in the United States for clinical use.

“  The first clinical feedback across Europe on our Stream17 and Cascade17 low profile devices has been positive from a growing group of neuroradiologists. Compatibility with 430 μm microcatheters is our priority, offering a privileged tool to better save patients' lives. This is the direct result of Perflow's commitment to continuous improvement, ”says Mark Vekemans, Director of Sales and Marketing at PerflowMedical. “Internally, we are committed to innovating in the neurovascular field and providing strong clinical evidence to support our technology. By the end of the year, we hope to be able to share additional clinical results for our Stream and Cascade product families. "

About Perflow Medical
Perflow Medical, a privately held medical device company based in Israel, develops and manufactures innovative solutions to treat complex neurovascular disorders. Perflow's patented CEREBRAL NET ™ Technology platform, a braided net that enables adjustable neurovascular treatments, emphasizes physician expertise by combining physician real-time control, advanced device manipulation, full-wall apposition and excellent radiopacity to improve patient outcomes. Their commercial product portfolio includes the Stream ™ Net, devices for the treatment of acute ischemic attacks and the Cascade ™ Net, devices for the treatment of intracranial aneurysms. To know more, www.perflow.com .

Latest Issue
Get instant
access to our latest e-book
Sanofi